EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CRISPR/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C

Mehran Reyhani-Ardabili, Mohadeseh Fathi, Soudeh Ghafouri-Fard

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09801-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mehran Reyhani-Ardabili und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Niemann-Pick Disease, Type C, Gene Editing, Genetic Therapy. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niemann-Pick disease type C (NPC) is a rare neurodegenerative condition resulted from mutations in NPC1 and NPC2 genes. This cellular lipid transferring disorder mainly involves endocytosed cholesterol trafficking. The accumulation of cholesterol and glycolipids in late endosomes and lysosomes results in progressive neurodegeneration and death. Recently, genome editing technologies, particularly CRISPR/Cas9 have offered the opportunity to create disease models to screen novel therapeutic options for this disorder. Moreover, these methods have been used for the purpose of gene therapy. This review summarizes the studies that focused on the application of CRISPR/Cas9 technology for exploring the mechanism of intracellular cholesterol transferring, and screening of novel agents for treatment of NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNiemann-Pick Disease, Type CGene EditingGenetic TherapyCholesterolHumansAnimalsNiemann-Pick C1 ProteinDisease Models, Animal

Stichwörter der Autor:innen

CRISPR/CasMutationNiemann-Pick C1

Substanzen

CholesterolNiemann-Pick C1 Protein

Autor:innen und Institutionen

  • Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. s.ghafourifard@sbmu.ac.ir.

Zitieren

APA

Reyhani-Ardabili, M., Fathi, M., & Ghafouri-Fard, S. (2024). CRISPR/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09801-1

Vancouver

Reyhani-Ardabili M, Fathi M, Ghafouri-Fard S. CRISPR/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09801-1

BibTeX
@article{ReyhaniArdabili2024,
  author = {Reyhani-Ardabili, Mehran and Fathi, Mohadeseh and Ghafouri-Fard, Soudeh},
  title = {CRISPR/Cas9 technology in the modeling of and evaluation of possible treatments for Niemann-Pick C},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09801-1}
}
Kostenlos starten →